Amanta Healthcare
AMANTA · Pharma > Pharmaceuticals & Drugs Listing date: Sept. 9, 2025

Stock Price vs Company Growth
1d
4.9%
1w
20.1%
1m
45.6%
3m
79.3%
6m
68.7%
all
35.7%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 191 4.9%
108
191
Company Overview

Sales
288 Cr
Growth: 4.9%
Profit after Tax
14.9 Cr
Growth: -2.8%
Small Cap
741 Cr
P/E: 42.2x
Industry P/E: 33.7x
Fundamentals

Sales (Cr) ₹ 288
Growth 4.9%
EBITDA 20.8%
P/S 2.6x
Dividend 0.0%
P/E 42.2x
Book Value ₹ 55.6
PEG Ratio 8.4x
ROE 11.2%
P/B 3.3x
Shareholding Pattern

Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed

The company is engaged in developing, manufacturing and marketing a diverse range of sterile liquid products - parenteral products, being packed in plastic container with ABFS and ISBM technology. It manufactures large volume parenterals LVPs and SVPs in therapeutic segments.Products of the companyFluid TherapySodium Chloride Intravenous Infusion B.P. (9g / L)Sodium Chloride Infusion U.S.P. (0.45 % w/v)Glucose Intravenous Infusion B.P. (50g / L)Glucose Intravenous Infusion B.P.
Investors (4)